CN Patent

CN116003469B — 嘧啶基抗病毒化合物的制备与使用方法

Assigned to Nanjing Zhihe Medical Technology Co ltd · Expires 2023-10-17 · 3y expired

What this patent protects

本发明提供一种新颖的嘧啶基抗病毒化合物的制备与使用方法。本发明的嘧啶基抗病毒化合物可用于治疗病毒所致疾病的作用，以及在治疗心肌缺血、肿瘤等疾病方面的应用。

USPTO Abstract

本发明提供一种新颖的嘧啶基抗病毒化合物的制备与使用方法。本发明的嘧啶基抗病毒化合物可用于治疗病毒所致疾病的作用，以及在治疗心肌缺血、肿瘤等疾病方面的应用。

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN116003469B
Jurisdiction: CN
Classification: —
Expires: 2023-10-17
Drug substance claim: No
Drug product claim: No
Assignee: Nanjing Zhihe Medical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.